1

Diabetic Foot Ulcer (DFU) Treatment Market (By Treatment: Wound Care Dressings [Alginate Dressings, Hydrofiber Dressings, Foam Dressings, Film Dressing, Hydrocolloid Dressings, Surgical Dressings, Hydrogel Dressings], Biologics [Growth Factors, Skin Grafts], Therapy Devices [Negative Pressure Wound Therapy, Ultrasound Therapy], Antibiotic Medications, Others; By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Diabetic Foot Ulcer (DFU) Treatment
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Diabetic Foot Ulcer (DFU) Treatment Market By Treatment
                 1.2.2.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison By Treatment (2015-2026)
                 1.2.2.2. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share By Treatment in 2017
                 1.2.2.3. Wound Care Dressings
                 1.2.2.4. Biologics
                 1.2.2.5. Therapy Devices
                 1.2.2.6. Antibiotic Medications
                 1.2.2.7. Others
       1.2.3. Diabetic Foot Ulcer (DFU) Treatment Market By Ulcer Type
                 1.2.3.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison By Ulcer Type (2015-2026)
                 1.2.3.2. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share By Ulcer Type in 2017
                 1.2.3.3. Neuropathic Ulcers
                 1.2.3.4. Ischemic Ulcers
                 1.2.3.5. Neuro-ischemic Ulcers
                 1.2.3.6. Others
       1.2.4. Diabetic Foot Ulcer (DFU) Treatment Market by Geography
                 1.2.4.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.4.2. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.4.3. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.4.4. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.4.5. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.4.6. Middle East and Africa (MEA) Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017

CHAPTER 4. DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY TREATMENT

4.1. Global Diabetic Foot Ulcer (DFU) Treatment Revenue By Treatment
4.2. Wound Care Dressings
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Biologics
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Therapy Devices
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Antibiotic Medications
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY ULCER TYPE

5.1. Global Diabetic Foot Ulcer (DFU) Treatment Revenue By Ulcer Type
5.2. Neuropathic Ulcers
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Ischemic Ulcers
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Neuro-ischemic Ulcers
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

6.1. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
       6.3.1. U.S. Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
6.4. Canada
       6.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
6.5. Mexico
       6.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

7.1. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
       7.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.4. Germany
       7.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.5. France
       7.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.6. Spain
       7.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
       7.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

8.1. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
       8.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.4. Japan
       8.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.5. India
       8.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.6. Australia
       8.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.7. South Korea
       8.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
       8.8.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.8.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

9.1. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
       9.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
9.4. Argentina
       9.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
       9.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

10.1. Middle East Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
         10.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
10.4. UAE
         10.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East
         10.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY

11.1. Africa Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
         11.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
11.4. Egypt
         11.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
11.5. Rest of Africa
         11.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. BSN Medical GMBH
         12.1.1. Company Snapshot
         12.1.2. Overview
         12.1.3. Financial Overview
         12.1.4. Product Portfolio
         12.1.5. Key Developments
         12.1.6. Strategies
12.2. ConvaTec, Inc.
         12.2.1. Company Snapshot
         12.2.2. Overview
         12.2.3. Financial Overview
         12.2.4. Product Portfolio
         12.2.5. Key Developments
         12.2.6. Strategies
12.3. Molnlycke Health Care AB
         12.3.1. Company Snapshot
         12.3.2. Overview
         12.3.3. Financial Overview
         12.3.4. Product Portfolio
         12.3.5. Key Developments
         12.3.6. Strategies
12.4. Acelity L.P. Inc.
         12.4.1. Company Snapshot
         12.4.2. Overview
         12.4.3. Financial Overview
         12.4.4. Product Portfolio
         12.4.5. Key Developments
         12.4.6. Strategies
12.5. Organogenesis, Inc.
         12.5.1. Company Snapshot
         12.5.2. Overview
         12.5.3. Financial Overview
         12.5.4. Product Portfolio
         12.5.5. Key Developments
         12.5.6. Strategies
12.6. 3M Healthcare
         12.6.1. Company Snapshot
         12.6.2. Overview
         12.6.3. Financial Overview
         12.6.4. Product Portfolio
         12.6.5. Key Developments
         12.6.6. Strategies
12.7. Medtronic Plc.
         12.7.1. Company Snapshot
         12.7.2. Overview
         12.7.3. Financial Overview
         12.7.4. Product Portfolio
         12.7.5. Key Developments
         12.7.6. Strategies
12.8. Coloplast A/S
         12.8.1. Company Snapshot
         12.8.2. Overview
         12.8.3. Financial Overview
         12.8.4. Product Portfolio
         12.8.5. Key Developments
         12.8.6. Strategies
12.9. Medline Industries, Inc.
         12.9.1. Company Snapshot
         12.9.2. Overview
         12.9.3. Financial Overview
         12.9.4. Product Portfolio
         12.9.5. Key Developments
         12.9.6. Strategies
12.10. Smith & Nephew Plc.
         12.10.1. Company Snapshot
         12.10.2. Overview
         12.10.3. Financial Overview
         12.10.4. Product Portfolio
         12.10.5. Key Developments
         12.10.6. Strategies
12.11. B. Braun Melsungen AG.
         12.11.1. Company Snapshot
         12.11.2. Overview
         12.11.3. Financial Overview
         12.11.4. Product Portfolio
         12.11.5. Key Developments
         12.11.6. Strategies
12.12. Others
         12.12.1. Company Snapshot
         12.12.2. Overview
         12.12.3. Financial Overview
         12.12.4. Product Portfolio
         12.12.5. Key Developments
         12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
         13.1.1. Initial Data Search
         13.1.2. Secondary Research
         13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary